Drug repurposing: progress, challenges and recommendationsSudeep Pushpakom, Munir Pirmohamed, Patrick A. Eyers et al.|Nature Reviews Drug Discovery|2018Cited by 4.6k
A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation studyJesse J. Swen, Roelof Bosch, Cathelijne H. van der Wouden et al.|The Lancet|2023Cited by 508
Pragmatic randomised trials using routine electronic health records: putting them to the testTjeerd van Staa, Liam Smeeth, Ben Goldacre et al.|BMJ|2012Cited by 172
Genotype-Guided Dosing of Coumarin Derivatives: The European Pharmacogenetics of Anticoagulant Therapy (EU-PACT) Trial DesignRianne MF van Schie, Anke H. Maitland‐van der Zee, Mia Wadelius et al.|Pharmacogenomics|2009Cited by 146